Clinical trial
Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis
NCT00301509 · Casa Sollievo della Sofferenza IRCCS, Other · Completed
Key facts
| NCT number | NCT00301509 |
|---|---|
| Title | Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis |
| Official title | Outcome of Decompensated Hepatitis C Virus-Related Cirrhotic Patients Treated With Peginterferon Alfa-2b and Ribavirin: Results of a Controlled Study |
| Lead sponsor | Casa Sollievo della Sofferenza IRCCS, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Liver Cirrhosis, Experimental |
| Intervention type | Drug |
| Interventions | peginterferon and ribavirin |
| Start date | Jan 1, 2002 |
| Completion | Dec 1, 2005 |
| First posted | Mar 13, 2006 |
| Last update posted | Mar 13, 2006 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: